Tech Company Financing Transactions
Canid Funding Round
On 9/22/2023, Canid raised $1.5 million in funding from SeedToB Capital, Alumni Ventures and FJ Labs.
Transaction Overview
Company Name
Announced On
9/22/2023
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand its geographic presence to 10 new states across the U.S. and add new tools to manage vaccine patient populations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9 West 24th Street
New York, NY 10010
USA
New York, NY 10010
USA
Phone
Website
Email Address
Overview
We built Canid because we believe vaccinating shouldn't be hard, and it shouldn't be a distraction from what's most important: taking care of the kids. Today's healthcare system is plagued by administrative and financial burden and it's killing private practices, driving the formation of hospital oligopolies. This is bad for patients, doctors, and payers alike. At Canid, we're driven by the value and importance of supporting private pediatric practices. We are passionate about building solutions that make running a practice's vaccine program easier and financially sustainable for small pediatric practices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pedro Lozada
Browse more venture capital transactions:
Prev: 9/22/2023: Falcomm venture capital transaction
Next: 9/23/2023: Secoda venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs